Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Chemical Information
Until recently, this strategy was a clinical adjustment without a head-to-head trial behind it
While glucagon increases blood glucose levels via stimulating the liver to release glucose, glucagon-like peptide-1 (GLP-1) has pretty much the opposite effect in that it can decrease blood glucose by stimulating more insulin to be released by the beta-cells in the pancreas.[ref] GIP (glucose-dependent insulinotropic peptide) not only acts on the GIP receptor (GIPR) in the pancreas, but it also acts upon other tissues such as fat, bone, and endothelial cells lining blood vessels
Subcutaneous injections involve injecting the peptide just below the skin, specifically into the fatty tissue layer
